Consistent with this, IL-6 protein expression levels in AEC2 cells were significantly higher in patients with COVID-ARDS compared to those with IPF alone or IPF with COVID history (Fig. 5A, D). This evidence concerns the gene IL6 and idiopathic pulmonary fibrosis.